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ONE of the more striking changes in the climate of physiological and
pharmacological opinion, both in the laboratory and in the clinical field, is the
interest taken in deliberately lowering blood pressure. Ten or twenty years ago
a blood pressure below 100 mm. Hg. was regarded, in general, as undesirable,
and the clinician would be tempted to start vigorous therapy, for instance, by
blood transfusion or sympathomimetic amines. But recentlv two important things
have happened. On the one hand, ganglion blocking agents have proved able
to benefit malignant hypertension, and to do this (it seems) in proportion to their
ability to reduce the blood pressure; on the other hand, lowering the blood pressure
has been found useful at surgical operation, to diminish hamorrhage and possibly
to confer other advantages. One only appreciates this change of opinion if one
looks back at older papers and sees, for instance, how the argument was advanced
that high blood pressure in hypertension was a u(sefutl compensation, ensuring a
satisfactory blood supply to organs in the presence of constricted arterioles.
Not all the fruits of the change of opinion are entirely beneficial. The blood
pressure is sometimes lowered too often, too far, and too long. But such hypo-
tension is clearly not intrinsically as dangerous as it was thought to be; and
to produce it, by means which are understood and controllable, places in the hands
of the clinician a therapeutic weapon of the first importance. At the same time
the fashion for hypotension of one sort or another leads sometimes to failure to
distinguish the means by which this hypotension is brought about. Accordingly,
I want to start by some quite simple remarks "comparing and contrasting" (as
examination papers have it) the various means by which a reduction of systemic
blood pressure can be achieved by the use of drugs. Suppose one considers the
simple cardiovascular reflex arc from various afferent nerves, through the central
nervous system and out by the sympathetic outflow to arteriolar smooth muscles.
First there are substances like the veratrum alkaloids; these have a fairly complex
action, but a part of it at least is stimulation of vagal afferent nerves in the heart
and lungs (the so-called Bezold-Jarisch effect). As a consequence of the incoming
volley of impulses, the central nervous system reacts by producing a marked
slowing of the heart and some peripheral vasodilation. rhe response is abolished
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Fif the drug is preventedi from reaching the vagal afferents, if the vagus nerves
are cut, or if the central nervous system is destroyed. As a method of lowering
the blood pressure it has the interesting advantage that it does not weaken the
other reflexes controlling the blood pressure, so that postural hypotension does
not occur. But it possesses the disadvantage that the effects of the incoming
volleys on the central nervous system are not exclusively on the circulation.
There is also, as with so many reflex stimulants of this type, considerable malaise,
nausea, and even vomiting. It is difficult to find a close which secures the hypo-
tensive action wished for, without actively unpleasant side effects. This action of
veratrine is shared by a number of other compounds, by heterologous serum in
some animals, and perhaps by digitalis. It is an important action in principle,
which may yet come to major usefulness.
A second type of action is on the central nervous system. Drugs like pheno-
barbitone have an honourable history for a sedative action, by which the blood
pressure of a benign hypertensive may be restrained from at least the grosser
fluctuations. One presumes that phenobarbitone exerts its effect by depressing the
central drive on the sympathetic centres. Such a central sedative process is un-
doubtedly of great use in handling hypertensive patients, but it is limited by the fact
that the sedative will, if given in larger doses, inevitably cloud other central
activities. I am not aware of any central sedative which will produce large falls
in blood pressure without producing marked central signs, or even frank
anaesthesia.
Third are the drugs which interfere with the preganglionic nerves. At present
these are chiefly pharmacological curiosities. The preganglionic nerves are
cholinergic; and there are substances like local anaesthetics (Harvey, 1939),
botulinum toxin (Burgen, et al., 1949), and a recent compound which can be
regarded as or antimetabolite for acetylcholine synthesis (MacIntosh, et al., 1956),
as well as changes in ionic concentration at the nerve endings (notably Ca+ +
lack (Harvey and MacIntosh, 1940)), all of which interfere with the nerve terminals
so as to reduce the amount of acetylcholine released at the synaptic junctions in
the ganglion. As a result, one obtains a block of transmission in the ganglion due
to a lack of transmitter rather than an antagonism to the transmitter once released.
But this type of action is obviously useless to practice at present; botulinum toxin
poisons all cholinergic nerves so that a depression of autonomic outflow would
only be obtained at the expense of widespread neuromuscular block; focal
anaesthetics are too weak and non-specific; and the change in calcium concentration
required to produce the effect would throw any animal or patient into violent
tetany. This is another attack which doubtless will bear fruit in the future.
The fourth type of action to consider is the one in which we are primarily
interested, that of specific competitive ganglion block, whereby a drug like
hexamethonium stops the acetylcholine still normally released, from exciting the
ganglion cells in its usual way.
Fifth are the drugs which may interfere with the postganglionic neurone and
its nerve endings. A few years ago one nwould have made simply formal acknow-
ledgment of the possibility that an action might take place, but this is now more
18than a possibility. There is the xylyl choline ether known as TM 10 synthesised
by Hey and studied by Bain and his colleagues (Bain and Fielden, 1956) which
can depress adrenaline output. Miss Vogt in Edinburgh has recently shown
(Muscholl and Vogt, 1957) that reserpine can also depress adrenaline output in a
rather interesting way, by depleting the neurone of its stores of the transmitter,
in this case noradrenaline. Thus, although the nerve is in principle undamaged,
yet it cannot release its normal amounts of sympathin because its stocks have
been removed by some interference with its binding or metabolic production.
It is interesting too that there are signs that morphine also can interfere with the
release of transmitter at the post-ganglionic level.
Sixth, we have those drugs which can antagonize a transmitter once it has been
released at the peripheral site; that is to say, drugs like dihydrcergotamine or
dibenzyl[ne at the sympathetic sites. For lowering the blood pressure, of course,
the antiadrenaline drugs are of great importance, although perhaps they deserve
attention chiefly for investigative purposes rather than treatment.
The last (seventh) group of actions are those where the drug concerned has a
direct action on the smooth muscle of the arteriole wall, causing it to relax. Here
one has in mind things such as the nitrites or acetylcholine or histamine. But they
are all rather transient; and with one exception in principle, which I will discuss
later, that of histamine release from the body, I am not aware yet of any
particularly encouraging evidence that such drugs can be used for any length of
time for lowering the blood pressure.
THE PROOF OF GANGLION BLOCK.
Looking at the various methods of reducing the blood pressure, ganglion block
offers one significant advantage. This is that the autonomic outflow can be inter-
rupted without, on the one hand, any action of the central nervous system (such as
phenobarbitone exerts) nor, on the other hand, any action on the effector organ;
the latter thus retains its sensitivity to drugs like acetylcholine or adrenaline if
one wants to control an excessive degree of block. But this advantage with
ganglion block only exists if the blocking agent is in fact specific. To illustrate
what is meant by this, and to exemplify part of the work of pharmacological
research, I would like briefly to review the evidence one has to collect before
ganglion block can be taken as the sole action of a particular compound. The
work I am going to describe was done some years ago by Dr. Zaimis and myself
(Paton and Zaimis, 1951), and it will, I am afraid, be rather vieux jeu to some of
the physiologists present.
Such a drug usually comes to notice by producing a fall in blood pressure, or,
during stimulation of a preganglionic sympathetic nerve (which is quite commonly
done in exploratory experiments) by producing a failure of the effector response.
What is recorded is that at some step between the preganglionic nerve and the
final effector organ a depression of function has occurred. How are we to dis-
entangle the various possible causes? The first analytic step is to compare the
effects of stimulating the pre- and postganglionic nerves electrically. This is done
on the superior cervical ganglion, using the contraction of the nictitating
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Gmembrance as a sign of ganglionic activity. First of all, vou stimulate post-
ganglionically. Then you stimulate through the preganglionic electrodes. During
the latter you inject the drug under test, in this case hexamethonium. It produces
a complete depression of the effector response, as shown by the absence of further
relaxation when the stimulation is stopped. Now turn back to the postganglionic
stimulation; it is as effective as ever. Return to the preganglionic trunk, it is
still blocked. This shows that the drug has interfered with nothing "downstream"
from the postganglionic electrodes; in other words, the muscle itself, the action
of the peripheral transmitter, and its release, are all left unimpaired.
But we still have to distinguish between a drug which acts like hexamethonium
and one which depresses acetylcholine release at the nerve terminals. One has
to turn here to perfusion of the ganglion, so as to collect the acetvlcholine released
and to try whether the amount liberated by stimulation of the nerves before and
during the presence of the drug being tested is changed or not. One finds that
hexamethonium, even when injected in a relatively huge dose into a perfused
ganglion (about the size of a pea), produces no reduction of acetylcholine output.
Hence we conclude that the drug is what we are looking for in this case, something
which specifically blocks ganglia by competitive antagonism with acetylcholine at
the synapse.
All the work described has been done, of course, on a single ganglion. Since
ganglia are known to differ considerably in their responses, it is obviously safer
to conduct some tests on other ganglia. Unfortunately, one cannot do a rigorous
analysis on any other preparation than the superior cervical ganglion; but good
corroborative evidence can be obtained. Thus one can compare the response to
stimulating the vagus nerve with the response to acetylcholine, using as test-object
the rate of the heart. If the drug is a specific ganglion blocking agent it wlll
paralyse vagal stimulation but leave the response to acetylcholine (which acts
purelv peripherallv) quite unimpaired. It is found that hexamethonium does,
in fact, behave like this. Similarly, you can compare the response to stimulating
the ganglia by nicotine with the response of the blood pressure to adrenaline or
to acetylcholine. Figure 1 shows such an experiment. First of all are three
control responses to the three test drugs. Then in the middle panel some hexa-
methonium is given, producing, with a fairly small dose, a slow fall in blood
pressure dlue to relaxation of autonomic tone. Further big doses produce no
further fall, in itself a useful check that the drug does not have any further
actions on the heart or circulation. Then we repeat the test drugs and find that
acetylcholine can still lower the blood pressure, adrenaline can still raise it, but
nicotine is now completely ineffective. You will probably have noticed that the
responses to acetylcholine and adrenaline are changed, becoming prolonged, and
in the case of adrenaline, increased. These, of course, are due primarily to the
inactivation of the buffer nerves which normally check a rise or fall in blood
pressure; when their influence is removed, then the rise or fall can be more
prolonged and possibly greater.
From all this type of evidence one concludes that a drug like hexamethonium
is a specific ganglion blocking agent and free of other actions.
20Fig. 1.
Records of the l)lood pressure
of a cat amesthetised witl
chloralose.
T'op P'aniel: Normal i-esponses
to acetylcholine, adrenaline,
and nicotine, given intra-
venously.
.lliddle Panel: Response to
a mediunm dose of hexa-
methonium, followed I)y,
further large doses.
Lozoest I'aniel: Res.ponse to
acetylcholine, adrenaline,
and nicotinie after the hexa-
methonium.
(From Patoni and Zaililis, 1951
by permissioin of the Britisli
jontroial of Pharmacology.)
he knowledge whether a drug is specific or not is important; and 1 would like
to mention two additional points about hexamethonium. First, one of the things
that makes it specific is that it is a salt of quaternary nitrogen; without going into
detail, this means that its molecules can only exist in solution carrying a positive
charge-i.e., it is always fully ionised. Now such particles penetrate cell
membranes only with difficulty. his gives to hexamethonium the following
characteristic properties: poor absorption by mouth; distribution only in the extia-
cellular fluid; resistance to metabolism; excretion by the kidney roughly like
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60Linulin (neither traversing the cells of the tubules outwards in secretion, nor
inwards by reabsorption); and failure to enter the cerebrospinal fluid, which is
quite a sensitive test (Fig. 2). This means that any central actions of
hexamethonium (and they are not strong) are excluded by permeability
considerations.
Secondly, one must remember that ganglion block does not always lead to
quiescence of a structure. I remember being disconcerted to see how, in the cat
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0 Comparison, in a cat anaesthetised
10 with chloralose, of the concentration
f of hexamethonium in the cerebro-
5 5 spinal fluid with that in the plasma,
U. during infusion of a large dose of
hexamethonium.
- 2 (From Paton, 1952; by permission
Z of the Athlone Press.)
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under chloralose, hexamethonium and TEA can stir up the bowel (Fig. 3) (Paton
and Zaimis, 1951). But this is not a muscarinic or histaminic action; it can be
closely imitated by cutting splanchnic nerves-as described by Bayliss and Starling
many years ago; and is due to release of intrinsic intestinal activity from
sympathetic restraint, as hexamethonium paralyses the sympathetic ganglia.
OTHER GANGLION BLOCKING AGENTS.
Before going further, I ought to comment briefly on some of the other agents
which resemble hexamethonium in action (Fig. 4). Pentolinium is now familiar, and
resembles hexamethonium in all respects save for being more active and longer
in its action. Chlorisondamitne, likewise, is still more prolonged, possibly has a
mild stimulant action on the colon, but is still like hexamethonium in principle
22(Plummer, et al., 1955, 1956; Smirk and Hamilton, 1956). With mecamylamine
a new element comes in. For the first time we have an active agent, not
quaternary, which can be present (although only in small amounts) in the un-
charged form (Baer, et al., 1956; Moyer, et al., 1956; Doyle, et al., 1956). As
a result, it can penetrate membranes; it is well absorbed; it is distributed more
widely than the extracellular fluid. There are hints that it may partly be metabolised.
It is excreted in the urine in a rather interesting way: if the urine is acid (which
increases ionization of mecamylamine in it), mecamylamine is rapidly eliminated
(one supposes because it is not reabsorbed at all): if the urine is alkaline,
Fig. 3.
Cat, chloralose. Record of movements of small intestine. Intravenous injections. (a) At arrow,
0.24 mg. hexamethonium iodide per kg. (b) At arrow, 1.5 tetraethylammonium iodide per kg.
(From Paton and Zaimis, 1951; by permission of the British journal of Pharmacology.)
mecamylamine is very slowly eliminated (because now it can be reabsorbed). Thus
a single circumstance (that of not being quaternary) makes oral administration
convenient and duration of action controllable in principle (though it may not be
worth cfoing in practice). One must note, however, that by the same token that
mecamylamine is active by mouth, it may have an effect on the central nervous
system: and it is in this direction, perhaps, which most c-are should be taken
(cf. Doyle and Neilson, 1956).
The last blocking agent I would like to mention here is nicotine. I will not
expatiate on the electrophysiological experiment which Perry and I did to study
this type of action (Paton and Perry, 1953). Briefly, a drug like hexamethonium
simply interferes with transmitter action-pure block; at the opposite extreme are
drugs which imitate the action of the transmitter (like acetylcholine itself in excess)
and, so to speak, throw the ganglion into a state of vigorous activity such that
it can no longer respond to incoming signals-this is pure stimulant action. But
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Hbetween these extremes is a third; where a drug begins by stimulating, i.e.,
imitating the transmitter, and ends by blocking it; such a drug is nicotine; and
Fig. 5 (which I promise is free from any electrical symbol!) may exemplify the
differences mentioned.
I have introduced nicotine because this mixed type of action runs through the
whole of pharmacology; when you find that ergotamine is an adrenolytic yet
contracts cerebral vessels, that drugs exhibit "tachyphylaxis,". or that penicillin
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can sometimes stimulate the growth of organisms it usually inhibits, one is
probably dealing with just this confusing but thought-promoting phenomenon.
REDUCTION OF THE BLOOD PRESSURE BY HISTAMINE RELEASE.
I would like to introduce this by discussing another drug which has been widely
used for lowering the blood pressure at surgical operation to diminish bleeding,
and is reputed to be a ganglion blocking agent. This is the material usually known
as Arfonad, which has now received the official name "trimetaphan." If you
inject it into an animal you find that it can, indeed, paralyse ganglia and part of
its action seems undoubtedly like that of hexamethonium. But if you compare,
24S
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for instance, the effect on the blood pressure in relation to that on the superior
cervical ganglion (as measured by the contraction of the nictitating membrane)
with similar responses obtained with hexamethonium you will see there is a
considerable difference. In this particular experiment (Fig. 6) hexamethonium
was able to produce a profound ganglion block; yet the blood pressure was little
affected, because at the time there was little autonomic tone to be released.
But Arfonad, while producing quite a long-lasting ganglion block, produced a
distinct but transient change in blood pressure.
This blood pressure tracing is rather an interesting phenomenon. You can see
the point of injection by a little spike (due to a momentary increase in venous
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Fig. 5.-Responses of the nictitating membrane of the cat an.esthetised with chloralose.
(a) Comparison of tetramethylammonium (T.M.A.) and nicotine given intra-arterially
into the blood-supply of an unstimulated ganglion, showing comparable stimulant
action by both drugs.
(b) Comparison of nicotine, T.M.A., and hexamethonium given intra-arterially, while
the ganglion is being excited by shocks at 1/second applied to the preganglionic
cervical sympathetic trunk; showing the nearly pure stimulant action of T.M.A.,
the mixed action of nicotine, and the pure blocking action of hexamethonium.
return); then there is a latency of something like twenty seconds; finally, there
is quite an abrupt but transient fall in blood pressure. This is a very characteristic
example of what is called the "delayed depressor response," and it is characteristic
of a group of drugs which MacIntosh and I worked on some years ago, the
"histamine liberators" (MacIntosh and Paton, 1949). With many other compounds
you will see the same picture with the blood pressure: the point of injection, then a
latency, and then an abrupt fall followed by a recovery which depends on the dose
given (Fig. 7). We found that the drugs themselves were not primarily active on the
circulation; but that when they reached the tissues they released some of the
histamine contained there, the histamine then circulated back in the veins, through
the lungs and out again into the circulation, so that. the delay in the depressor
25
A
Iresponse is simply equivalent to one circulation time. Histamine, of course, is
quite a brief-acting drug, so that a histamine-liberator produces a fall in blood
pressure and recovery which is not unlike that due to histamine itself, except that
it is "stepped back" by the delay in the circulation time just mentioned. We proved
that histamine release was occurring by showing that with a larger dose of the
drug, histamine as such could be identified in the plasma.
If you inject such drugs intradermally they produce the triple response that
Lewis described, a local erythema first of all which then develops into a weal
with sometimes a red edge round it; and these two phenomena are accompanied
* 0
ARFONAD HEXAMETHONIUM
3mg 04mg
Fig. 6.-Comparison of the effect of Arfonad with that of hexamethonium (a) on transmission
through the superior cervical ganglion, as tested by the response of the nictitating membrane
to preganglionic stimulation at 10 shocks (second upper tracing) and (b) on the blood
pressure (lower tracing) in a cat anasthetised with chloralose. Injections are given intravenously.
by a third, the rather patchy flare extending two or three centimetres away from
the point of injection. Arfonad will produce this reaction too. A decisive test for
histamine release is to use cat's isolated perfused skin (Feldberg and Paton,
1951). This is a good preparation because the skin is full of histamine; yet the
histamine is sufficiently firmly attached not to leak out during the handling of
the skin which is involved in preparing it for perfusion. Further, you can perfuse
it with a saline solution, so avoiding some awkward interfering substances present
in blood. Figure 8 shows the effect of 100 jg of Arfonad in such a preparation;
it releases something like 0.75 Ig of histamine for each Ig of Arfonad which was
injected, quite a powerful release. To this we can add some of the known results
reported by other people on the effects of Arfonad (Randall, et al., 1949; McCubbin
and Page, 1952). Thus Arfonad (like other liberators) injected into a dog can
produce profound circulatory collapse with an engorged liver, a rise in portal
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Fig. 7.-Responses of the blood pressure of the cat under chloralose to the intravenous
injection of seven different histamine liberators.
(From MacIntosh and Paton, 1949; by permission of the Journal of Physiology.)
pressure and a change in coagulability of the blood-all the symptoms of
anaphylactoid shock. There seems no doubt that Arfonad can, in fact, release
histamine as well as blocking ganglia.
The question arises, of course, as to whether this release occurs in man. It is
quite easy to show on one's own skin that quite a dilute solution of Arfonad will
produce the weal and flare response which we have already mentioned (Mitchell,
27et al, 1951). Anaesthetists who look for it can see this response occurring during
intravenous infusion of Arfonad; the vein and sometimes the lymphatics in the
region become traced out by the urticarial response around them. Further, Payne
(1955) has recently found that if you take patients receiving Arfonad and sample
their gastric juice, you find that in these patients there is a definite secretion
of acid gastric juice, although with patients undergoing similar operations but
not receiving Arfonad the gastric juice remains more or less neutral.
One- has to regard Arfonad, therefore, as possessing two distinct actions:
ganglion block and histamine release. This seems to be important for under-
standing its action. It is often stated to be a ganglion blocking agent with a
brief effect. But you will probably have noticed in the figure that in fact the
duration of paralysis of the nictitating membrane it produced was really not very
much shorter than that of hexamethonium, and in fact I have never been able to
satisfy myself that it really is a drug of specially short action. On the other
hand, if it releases histamine it might well appear to be a drug of short action;
ARFONAD
100P9
HIST.
pg/m
4.0
TOTAL
HISTAMINE Fig. 8.
3-0. RELEASED Release of histamine from a piece of
cat's skin, isolated and perfused with
Locke's solution, by Arfonad.
2-0
-01
O 10 20 30 40 50 60 70 8o 90 100
VOLUME PERFUSED (ml)
for as soon as it had completed its mobilization of tissue histamine the released
histamine would be rapidly mopped up in the body, and the histaminic circulatory
effects would indeed be rather transient. We have to think of Arfonad as being
a drug with a potentially short action on the circulation, not because it is itself
rapidly destroyed in the body, but because its action is that of histamine release
on a background of ganglion block. When the infusion of drug is discontinued,
the concentration of Arfonad begins to fall in the body, histamine release ceases,
and the blood pressure begins to recover as the histamine is destroyed.
I have discussed Arfonad in some detail because it serves to illustrate two points.
The first is that it is a neat example of a drug which, although it is a ganglion
28Records ofcon-
traction ofthe cat's nicti-
tating membrane excited
bystimulation ofthe pre-
ganglionic cervical sym-
pathetic trunk at x, lo or
2o shocks per second
(denoted by continuous,
broken and dotted lines
-espectively). Above are
the responses to these
ratas of stimulation, for
one minute, in a normal
cat. Below are the re-
sponses obtained after
hexamethonium.
Increasing the rate of
stimulation in the pre-
sence of hexamethonium
does not necessarily lead
toabiggerpostganglionic
responsc; although the
change from i/second to
io/second in (a) does so,
the further acceleration
from to/second to 20/
secondin(b)actuallypro-
duces(afteraninitial aug-
mentation) a consider-
able increaseinblock.
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Fig. 9.
(From Paton, 1952; by perm.ssion of the Athlone Press.)
blocking agent, also has another action which can contribute to its circulatory
effects. It shows the importance of making quite sure that a given effect which
you have identified is, in fact, enough to account for all the actions of the agent.
Secondly, it has allowed me to mention to you some of the main actions of the
histamine releasing process. These are, in fact, quite widely diffused over a lot
of drugs (for a review, see Paton, 1957). Thus, morphine, and some of the
therapeutic diamidines used in trypanosomiasis (propamidine, stilbamidine and
29
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- 4 -.- - - - -4pentamidine) are histamine liberators. D-tubocurarine, the muscle relaxant, is
quite a good histamine liberator, good enough, in fact, to be used as a standard
drug for the purpose in many investigations. Strychnine, atropine and a number
of other agents can also release histamine, but only in rather large doses compared
to their ordinary therapeutic ones. Pethidine is a moderately active histamine
liberator, and this may lie at the case of some of the urticarial responses described
with it. All of these drugs can produce phenomena which look "allergic," yet
need no previous sensitization, but simply the direct mobilization of the histamine
locked in the mast cells of the tissues.
FACTORS CONTROLLING THE SENSITIVITY TO GANGLION BLOCKING AGENTS.
It is a striking fact about ganglion blocking agents that patients are rather
variable in their response to them. Variations up to one thousand-fold exist between
the dose which sometimes will produce a distinct effect and the dose which the
clinician sometimes has to use to obtain the wished-for result. The causes of this
variation are several-fold. The first one is that the effect of a ganglion blocking
agent depends on the activity of the ganglia on which it is acting. In part this
is simply a truism. Unless there is any autonomic tone existing in the organism
you will see no effect when the autonomic pathways are blocked. Indeed, it is
an interesting exercise to estimate, from the response of humans to ganglion
blocking agents, what autonomic activity is normally in operation. One can
surnmarize the result in the not too seriously intended "hexamethonium man."
"He is a pink-complexioned person, except when he has stood for a long time,
when he may get pale and faint. His handshake is warm and dry. He is a placid
and relaxed companion; for instance, he may laugh, but he can't cry because the
tears cannot come. Your rudest story will not make him blush, and the most
unpleasant circumstances will fail to make him turn pale. His collars and socks
stay very clean and sweet. He wears corsets and may, if you meet him out, be
rather fidgety (corsets to compress his splanchnic vascular pool, fidgety to keep
the venous return going from his legs). He dislikes speaking much unless helped
with something to moisten his dry mouth and throat. He is long-sighted and
easily blinded by bright light. The redness of his eye-balls may suggest irregular
habits and, in fact, his head is rather weak. But he always behaves like a
gentleman and never belches nor hiccups. He tends to get cold and keeps well
wrapped up. But his health is good; he does not have chilblains and those diseases
of modern civilization, hypertension and peptic ulcer, pass him by. He is thin
because his appetite is modest; he never feels hunger-pains and his stomach never
rumbles. He gets rather constipated so that his intake of liquid paraffin is high.
As old age comes on he will suffer from retention of urine and impotence, but
frequency, precipitancy, and strangury will not worry him. One is uncertain how
he will end, but perhaps if he is not careful, by eating less and less and getting
colder and colder, he will sink into a symptomless, hypoglycwmic coma and die,
as was proposed for the universe, a peaceful entropy death."
But the position is a little more interesting still. It also appears that the
ganglion blocking agent can make the ganglionic synapse more easily fatiguable.
30This means that if you increase the rate of stimulation, the proportionate block
begins to become greater. One obtains a ganglion which may conduct fairly well
at slow rates of excitation, but at faster rates it becomes quite deeply paralysed.
At the top of Fig. 9 you can see the normal response to three rates of stimulation,
1/sec. 10/sec. and 20/sec. In the middle you see the response to 1/sec. and
10/sec. in the presence of hexamethonium. Now in this particular situation at
lO0'sec. you are still getting some further improvement on the contraction,
although much less than normally. But if 10/sec. and 20/sec. are compared, you
see that as soon as you switch over to the faster rate of stimulation the ganglion
becomes more deeply paralysed; return to 10/sec. it recovers; stimulated faster
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Fig. 10.-Distribution of ganglion block over nine autonomic functions in forty-one subjects.
The left-hand column gives the function tested; S or P indicate whether it is sympathetically
or parsympathetically controlled. On the vertical lines, one for each subject, a filled circle
is given where the effect of hexamethonium 25 mg. subcutaneously exceeded a certain
magnitude, for each function tested.
(From Paton and Steinberg, 1956; by permission of the British Medical Journal.)
again it becomes more deeply blocked. This has the important consequence that
ganglion block will "pick out" those pathways which are being driven particularly
fast, but leave those which are proceeding at a quieter rate relatively unblocked.
I suspect this type of phenomenon explains some of the exaggerated responses to
ganglion blocking agents which are described from time to time.
A second important factor in the sensitivity of ganglia to blocking agents is
that they seem to differ in their responsiveness. In animal this is quite striking;
indeed Langley more than fifty years ago first described the phenomenon with
nicotine. Similarly with hexamethonium, it is much easier to paralyse the fibres
to the pupil than it is the nictitating membrane. In a whole animal it is easier
to paralyse salivary secretion than the activity of the vagus nerve; there are many
other similar examples. The same is true in man; I would like to illustrate this
with some results (Fig. 10) in an experiment which Miss Steinberg and I did at
University College in a students' practical class (Paton and Steinberg, 1956).
The students were arranged in teams of four with one volunteer receiving
the drug (25 mg. hexamethonium s.c.) and three making systematic observations
of various autonomic functions. Then we analysed the results, according to whether
there had been a significant effect on particular autonomic functions studied or not,
and the figure shows the results on forty.one students on which satisfactory
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Lrecords were obtained. The outstanding thing about this experiment is that every
student had a different pattern of autonomic block. Some would have a postural
hypotension, to the verge of fainting, without any effect on the pupil or the reaction
to accommodation. Others would have quite a marked effect on the eyes and yet
very little effect on the blood pressure. It was remarkable that even in a single
ganglion, the ciliary ganglion, you might find paralysis of the pupil and not of
accommodation, or paralysis of accommodation and not of the pupil; it seemed
as though you could produce a sort of Argyll-Robertson pupil or inverse Argyll-
Robertson pupil according to the individual. One has therefore to allow for a
substantial variation from one individual to another, and from one ganglion to
another.
An analogous point is this, that it is difficult to produce complete block with
these drugs. If, for instance, you give maximum doses of hexamethonium to an
aneasthetised animal, you will still fail to lower its blood pressure as far as can
be done by destroying the spinal cord; and there are other examples illustrating
the difficulty of paralysing all the ganglia in the body. Now there is an analogous
clinical situation here, in the difficulty met by the surgeon undertaking
sympathectomy. There are many ganglia in the sympathetic system which are not
located in the sympathetic chains normally drawn in the text books, but are hidden
away in spinal nerves, in rami communicantes, sometimes found approaching
the spinal canal itself (cf. Boyd and Monro, 1949). Now we know that hexa-
methonium, and quaternary salts like it, penetrate into the cerebrospinal fluid
only with great difficulty, so that it cannot reach structures which are definitely
within the cerebrospinal axis. But we know also that it can reach ganglion cells
in the superior cervical ganglion, and in the heart and in the intestine, and so on.
The interesting question arises as to where the barrier to diffusion of these
quaternary salts disappears as you move out from the central nervous system
to the peripheral nervous tissue. It seems quite possible that the change of
accessibility of ganglia to compounds of this sort is not abrupt as you come
through the vertebral laminae, but may actually occur somewhere along a nerve
trunk; so that any ganglion cells which have not been fully extruded into the
normal sympathetic chains may, in fact, be simultaneously inaccessible, and for
the same reason, not only to the surgeon's knife but also to the pharmacologist's
syringe.
THE RESPONSE TO SYMPATHECTOMY.
This brings me to a rather different topic. I mentioned that one of the surgeon's
difficulties in sympathectomy is that he cannot remove all the sympathetic ganglia.
It was shown quite a long time ago by Simeone, Cannon, and Rosenblueth that if
you cut the majority, but not all, of the preganglionic fibres to a ganglion there is a
remarkably rapid recovery of function. Recently Murray and Thompson (1957),
in my laboratory, have been re-examining this phenomenon. Figure 11 illustrates
what happens. Supposing you cut down the number of fibres in the preganglionic
trunk of the cervical sympathetic in the neck by sectioning the rami where they
leave the spinal nerves from the thoracic 1, 2, and 3 segments. This means that
the remaining fibres, contributed by segments T4-7, now are the only ones
32supplying the superior cervical ganglion. TI, 2, and 3 contribute about 90 per cent.
of the fibres, T4-7 the remaining 10 per cent. If you stimulate the residual 10
per cent. in a normal ganglion only a small ganglionic response detectable, and
electrically there is a much reduced ganglion action potential. But if you now wait
for five or six weeks and then repeat the experiment, again stimulating the residual
10 per cent. coming from T4-7, you find that there is an enormous recovery of
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Fig. 11.-Upper Panels: Responses of the nictitating membranes of a cat ansesthetised with
chioralose on (a) the operated side, on which rami T1-3 had been divided forty-nine days
previously, and on (b) the normal side. The smaller responses are due to four shocks at
one shock/second delivered every minute, the larger responses to shocks at 10/second for
two minutes, the shocks applied to T4-7 on both sides simultaneously.
Middle Panels: Contractions of the nictitating membranes on the two sides to intravenous
adrenaline and noradrenaline, showing absence of supersensitivity on operated £side.
Lowest Panels: Records of ganglion action potentials (G.P.) fromn another animal in wvhich,
on the operated side, rami T1-3 were cut seventy days previously. In (a) T4-7 are stimulated;
in (b), first T4-7, then the whole preganglionic trunk.
(From Murray and Thompson, 1957; by permission of the Journal of Physiology.)
function. The contraction of the nictitating membrane is normal; the action
potential is as large as originally.
Now the question arises as to how this return of function has taken place.
Firstly, it cannot be attributed to regeneration from the sectioned rami; the time
is far too short. Nor is it due to supersensitivity; this appears earlier, but it
.33disappears as recovery of function becomes complete; and in the figure you will
see a test of the response of the nictitating membrane to adrenaline and nora-
adrenaline, showing the responses hardly distinguishable from normal. So that
one requires some mechanism for return of function which does not depend on
regeneration of the damaged fibres nor on sensitization of the structures whose
nerves have been interfered with.
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Fig. 12.-Diagram of an area of superior cervical ganglion of the cat, five days after section
of rami Tl-3, showing two sprouts arising from a normal parent preganglionic fibre, and
typical fragments of degenerating preganglionic terminals.
(From Murray and Thompson, 1957; by permission of the Journal of Physiology.)
The answer lies in the part played in the recovery by the remaining normal
fibres. These begin to give off little "sprouts" as they are called, small axoplasmic
shoots which enter the Schwann tubes of the degenerating nerves. These tubes
then guide the sprouts to the deprived ganglion cells and reinnervation takes place
by these means. The process of sprouting is a very rapid one, and is histologically
obvious within four or five days from the first section of some of the sympathetic
34preganglionic fibres (Fig. 12). The efficiency of the sprouting is enormous since
it can, as we have just seen, allow 10 per cent. of the fibres to restore the function
of the whole.
`
You will probably have suspected the occurrence of a rather interesting feature
of this form of response to injury. The fibres which were left behind, the residual
10 pei cent., normally innervate only a particular group of ganglion cells. In the
present circumstances they normally do not run to the ganglion cells supplying the
pupil at all, but only to the nictitating membrane and to vascular structures and
hair follicles. But if sprouts from them enter channels normally traversed by other
nerve fibres they are liable to be brought into communication with ganglion cells
which they do not normally touch. This is shown rather nicely by the fact that,
after the process of sprouting has developed, the residual 10 per cent. of fibres
now begins to be able to produce a transient dilatation of the pupil; as the
sprouting develops this dilatation becomes better and better sustained and finally
approaches the normal response. Thus the phenomenon brought about by sprouting
is not only a return of function, but also a redirection, a "re-routing" of the
autonomic nervous system, such that preganglionic fibres come to innervate
additional and novel structures.
Murray and Thompson have gone into some of the other properties of these
sprouted fibres, one of which I would like to mention. The synapse made by the
sprouted fibres is more sensitive than usual to ganglion blocking agents. A dose
of hexamethonium which normally has little effect on the nictitating contraction
will have quite a substantial effect when tested against a contraction of similar
height but mediated by a sprouted system. This last observation probably serves
to explain one of the rather interesting results which have been reported following
sympathectomv. Sometimes surgeons have sympathectomized a patient for
hypertension, and found that, after a period of reduced blood-pressure, the
hypertension returns, and in a time rather soon for regeneration. This is itself
odd; but the situation is made odder still by finding that in these patients, in which
presumably the autonomic nervous system is much reduced in importance, they
are still sensitive or even hypersensitive to ganglion blocking agents. From what
I said earlier, however, about the existence of accessory ganglia, you will have
recognised that sympathectomy provides a happy huntingwground for sprouting
(if I may mix my metaphors). Wherever you get ganglionic pathways which are
unimpaired adjacent to others which are sectioned, there will be possibility of
restoration of function in the damaged fibres by sprouting from the residual ones.
This may well explain the return of function after apparently successful sympathec-
tomies. Further, the observation which Murray and Thompson made about the
special sensitivity to hexamethonium would again lead one to expect that these
patients, after return of function, should still be sensitive or more sensitive to such
blocking agents.
There is another aspect of the sprouting story which I think will deserve a good
deal of exploitation. As one looks through the field of clinical surgery in the
sympathectomy field and through some of the curious physiological oddities
following denervation which have been recorded, one realises that the possibility
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Mof sprouting is a very important one to take into account. One can expect, I
think, fairly confidently that sprouting of this sort may occur wherever nerves of
similar types come into relationship. By this I mean that supposing a sympathetic
preganglionic trunk is sectioned, if there happen to be other cholinergic nerves
in the vicinity then these, as well as another sympathetic preganglionic trunk,
may well sprout and establish effective connection with the ganglion cells which
have been deprived of their nerves. If one takes the clinical phenomenon of
gustatory sweating, for instance, it is not impossible that sprouts grow from axons
normally involved in gustatory responses into the sympathetic preganglionic
pathways left behind after a sympathectomy. Likewise, the Sherrington
phenomenon, the Rogowicz phenomenon and the Philipeaux-Vulpian phenomenon,
conditions where contractures follow the excitation of nerves which are not
normally motor, may involve the ingrowth of cholinergic nerves into trunks which
have been deprived of their normal nerve fibres. The more one digs below the
surface among the sequele to operations of denervation, the more one appreciates
that the sprouting of one set of intact nerve fibres into the degenerating Schwann
tubes of another set is a consideration to be taken very seriously. The autonomic
nervous system is extraordinary not only in the versatility of the reactions which it
mediates, but also in the effectiveness of the repair process which takes place
when it is damaged.
THE CONSEQUENCES OF LOWERING THE BLOOD PRESSURE.
I would like now to be somewhat speculative (and correspondingly vulnerable)
in comparing what can be regarded as two main methods of lowering the blood
pressure. On the one hand, one can take a group of prqcedures such as spinal
anaesthesia, ganglion block, or the administration of a drug which paralyses the
peripheral sympathetic terminations. By all these manceuvres one can obtain a
profound fall in blood pressure, and a marked sensitivity to posture; but the
circulating blood volume is normal, and there is a peripheral vasodilation. Despite
the low blood pressure, blood flow to many of the organs may be normal or even
increased. On the other hand one has a group of procedures which may lead to
what is called "shock." This includes haemorrhage, histamine infusion or release
in large amounts, traumatising a limb or prolonged application and then release
of a tourniquet, the effect of burns or the crushing of the skin or of a limb. In
all these and in other cases there is a reduction of the circulating blood volume,
either by frank withdrawal of blood, or by leakage of fluid into tissue spaces out
of the circulation; and there is also a vigorous sympatho-adrenal response. The
total result is an intense vasoconstriction, so that even though the blood pressure
may be partly restored by this reaction, the blood flow to essential areas may be
quite seriously cut down. It is quite clear, for instance, that after these procedures
the circulation through the gut, the kidney, the liver and the skin, and possibly
sometimes the heart and brain, are quite considerably reduced. There is a very
curious phenomenon which occurs with the second group of reactions which does
not seem to occur, or has not yet been observed with the first group of hypotensive
procedures. This is the phenomenon known as "irreversible" shock, meaning by
this simply that the hypotension and peripheral circulatory failure become incurable
36whatever treatment you care to give; and it is liable to occur whenever the shock
persists longer than a few hours. If I may be frivolous for a moment; I hope
you will not think the concept of irreversible shock is a modern one. That in-
comparable physiologist, Jane Austen, describes it in Sophia's dying words to
Laura: "Beware of fainting fits.... Though at the time they may be refreshing
and agreeable yet believe me they will in the end, if too often repeated and at
improper seasons, prove destructive to your constitution.... A frenzy fit is not
half so pernicious."
This phase of irreversible shock is one of which a good deal of work, some
of it rather uncritical, has been devoted (cf. Green, 1953). The possible causes of
the irreversible phase which have been canvassed include (1) the release of
vasodepressor material (identified by at least one group of workers as the material
called ferritin which is involved in iron metabolism); (2) the growth of anaerobic
organisms in the liver with production of toxins; (3) a hypercoagulability of the
blood and formation of "micro-clots" in the circulation with progressive occlusion
of blood flow in lungs and elsewhere; (4) chronic tissue anoxia with liberation of
unspecified toxins or local damage to cells. None of these possibilities can be
either proved or excluded on the evidence at present available. But the point which
I would like to make now is that all of them can be regarded as flowing from the
exaggerated vasoconstriction which follows such "shock" procedures. Clostridial
organisms can flourish in an ischaemic liver, blood clots form more easily in a
slowly flowing stream; ischaemia of tissue certainly releases vasoactive materials.
ADRENALINE SHOCK.
We have then two conclusions, the first that if hypotension is produced by a
method which, amongst other things, inactivates the whole sympatho-adrenal
discharge, then it appears to be relatively safe for prolonged periods; but on the
other hand, with other types of hypotension which this discharge is called into
being and is intense, the hypotension may become irreversible. Secondly, the
theories which are called into play to explain the irreversibility all seem to focus
one way or another on the vasoconstriction as being the damaging factor.
I would like to mention here a third point to consider, the rather interesting and
neglected phenomenon known as adrenaline shock. Continuously or massively
administered adrenaline is quite dangerous. This was first recognised in the 1914-18
war and has been repeatedly confirmed (Bainbridge and Trevan, 1917; Erlanger
and Gasser, 1919). If a massive dose of adrenaline was injected into the liver,
for instance, a syndrome not unlike that of anaphylactic shock occurred. A very
interesting study was made by Blackett, Pickering, and Wilson (1950), in which
they compared the effects of infusing continuously adrenaline, noradrenaline and
renin into unanaesthetised rabbits. They found that with adrenaline and
noradrenaline the requirement of these hormones to produce a given blood pressure
continuously rose and that when the infusion ceased the blood pressure fell abruptly
and approached lethality. But this lethal process did not depend upon the height
of the blood pressure or the vasoconstriction producing it, since a satisfactory
hypotension could be easily maintained with renin for as long as was desired;
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Nand when the infusion stopped the blood pressure returned quietly to normal.
Later it has been found that with continued administration of adrenaline a defect
of capillary permeability may appear, leading to a loss of plasma to the tissues
and there may be hawmorrhages in the pericardium and in the intestine (Freeman,
et al., 1941). It is clear that this danger of adrenaline shock is more intense with
adrenaline than with noradrenaline. On the practical side it seems to be relatively
easily avoided by using noradrenaline if an agent of this sort is required, and
by seeing that when the infusion is stopped the drug is slowly tapered off and not
abruptly removed. But it is significant that the continued administration of these
natural substances, a thing which may well be happening during a prolonged
sympathoadrenal discharge in "shock," may in fact be quite deleterious to the
body. In fact one wonders whether part of the so-called irreversible stage of
shock may be marked not so much by some new event to do with the shocking
process, as by a development of adrenaline shock as a consequence of an overactive
and too prolonged reaction to the body to the original damage.
To all this we can add a last bit of evidence which seems to be slowly becoming
clear. If you subject animals to haemorrhagic or other types of shock, correspond-
ing to those occurring in man, they seem to survive better if their sympatho-adrenal
reaction is blocked. Thus dogs treated with dibenamine may enter the irreversible
stage of shock less readily (Remington, et al., 1950; Lotz, et al., 1955). Rats in
which tourniquet shock is produced may survive better if treated with hexa-
methonium (Spoerel, 1955). There is another rather different example which is
interesting; if you poison mice with anticholinesterases you find that after treatment
with hexamethonium they may be protected as much as ten-fold against the poison,
protection which may in fact considerably exceed that afforded by the conventional
antagonist atropine (Parkes and Sacra, 1954). So there is evidence that if you
remove this particular response of the body to various stressful situations, then
so far from survival being impaired, it may in fact be improved. I think it is not
unfair to mention too the interest taken in procedures such as cooling and ganglion
block, and the use of central depressants of various sorts to make a patient more
fit for various operative procedures, yet with the expressed intention of abolishing
the autonomic responses.
THE PHYSIOLOGICAL SIGNfFICANCE OF THE AUTONOMIc NERVOUS SYSTEM.
The conclusions I have just been outlining, if they are followed to a logical
conclusion, produce the rather disconcerting result that the autonomic nervous
system may be a substantial liability to the body, and it is this last possibility
which I would like briefly to examine. The usual teaching about the sympatho-
adrenal system is based on the work of Cannon and is expressed in the classical
statement that it is a system which confers an advantage on the organism when
it meets emergency of some sort, resulting in the need for staying to fight, or
taking flight, or expressing fright. It is fairly obvious, I think, from several lines
of study that the system is not essential for ordinary life. Cannon (1930) himself
showed that, after the sympathetic nervous system had been ablated, a cat could
still lead a relatively normal life. It is true that he probably did not remove as
38much of the system as he thought, in the light of our new knowledge about
accessory ganglia, but there was no doubt that he did attenuate it considerably.
Similar work has been done on the dog yielding quite similar results (MacDonough,
1939).
Added to this you can consider the progress of patients who have been
sympathectomised or treated with ganglion blocking agents. It is true that their
activities are somewhat modified and there are a number of side actions accompany.
ing ganglion block to which adaptation is needed. But if you think of other
structures of the body such as the adrenal cortex, the pituitary gland, the kidneys,
or the liver, you can immediately recognise that the autonomic nervous system
does not occupy a point of comparable vital importance. One could fairly suggest
that whatever the autonomic nervous system's importance may have been for
some lower organi-sm, it no longer occupies such a key position for mammalian life,
or in particular for human life. Indeed, its presence may in fact confer a liability,
in that it makes possible the play of emotion of all sorts of our viscera, and so
gives rise, perhaps, to the psychosomatic diseases, and conditions such as peptic
ulcer and hypotension in their neurogenic aspect. It is worth while to balance
up mentally (though, of course, artificially) the physiological loss which would be
incurred by abrogating our right to an autonomic nervous system, against the
clinical gain by the number of diseases from which we would be freed.
But, of course, Cannon's view on the sympathetic was that its r6le was not in
normal life but under emergency conditions. I think it is this concept particularly
which has been eroded of recent years. I do not see how one could predict, if
this was really true, that the inactivation of the sympathetic by dibenamine or
the paralysis of autonomic ganglia by drugs should really favour survival in
situations such as haemorrhage, tourniquet shock or poisoning with anticholine-
sterases; or that the human organism should be more ready for elaborate and
taxing surgical operation when all its autonomic defences are shattered by
refrigeration and whole batteries of paralytic cocktails. One gains, instead, the
impression that the autonomic system is an evolutionary heritage which, however
useful in our ancestral past, now seems to be out of gear with the requirements
of human social life with its continued and varied emotional pressures. This is a
philosophical, and nearly untestable idea. Yet I personally find it a stimulating
one, as well as one which can produce heated argument. Certainly it serves to
show that we cannot, even now, give a satisfactory account of the system-not
even of the reactions to a fall in blood pressure; and to remind one how
much there is still to do in a field in which-as does not always happen-the
pharmacologist and the surgeon can happily and profitably hunt together.
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